OGN Organon & Co

  1. Stocks
  2. Healthcare
  3. NYSE: OGN

Price (delayed)

$22.19

Market cap

$5.71B

P/E Ratio

5.41

Dividend/share

$1.12

EPS

$4.1

Enterprise value

$13.85B

Highlights
The equity has soared by 169% QoQ and by 107% YoY
Organon's net income has increased by 40% YoY and by 2.3% from the previous quarter
The gross margin has contracted by 5% YoY
OGN's gross profit is down by 2.2% year-on-year
Sector: Healthcare
Industry: Drug Manufacturers - General
Peers: OPK OPTN

Key stats

What are the main financial stats of OGN
Market
Shares outstanding
257.17M
Market cap
$5.71B
Enterprise value
$13.85B
Valuations
Price to earnings (P/E)
5.41
Price to book (P/B)
118.18
Price to sales (P/S)
0.89
EV/EBIT
11.54
EV/EBITDA
9.59
EV/Sales
2.18
Earnings
Revenue
$6.35B
EBIT
$1.2B
EBITDA
$1.44B
Free cash flow
$511M
Per share
EPS
$4.1
Free cash flow per share
$2
Book value per share
$0.19
Revenue per share
$24.82
TBVPS
$25.69
Balance sheet
Total assets
$11.89B
Total liabilities
$11.84B
Debt
$8.71B
Equity
$48M
Working capital
$1.65B
Liquidity
Debt to equity
181.54
Current ratio
1.65
Quick ratio
0.83
Net debt/EBITDA
5.64
Margins
EBITDA margin
22.8%
Gross margin
59%
Net margin
16.5%
Operating margin
19.5%
Efficiency
Return on assets
9.1%
Return on equity
N/A
Return on invested capital
10.1%
Return on capital employed
12.8%
Return on sales
18.9%
Dividend
Dividend yield
5.05%
DPS
$1.12
Payout ratio
27.3%

OGN stock price

How has the Organon stock price performed over time
Intraday
0.54%
1 week
5.77%
1 month
7.56%
1 year
-0.45%
YTD
53.88%
QTD
7.2%

Financial performance

How have Organon's revenue and profit performed over time
Revenue
$6.35B
Gross profit
$3.75B
Operating income
$1.24B
Net income
$1.05B
Gross margin
59%
Net margin
16.5%
Organon's net income has increased by 40% YoY and by 2.3% from the previous quarter
Organon's net margin has increased by 36% YoY
OGN's operating margin is down by 14% year-on-year
The company's operating income fell by 11% YoY

Growth

What is Organon's growth rate over time

Valuation

What is Organon stock price valuation
OGN P/E details
P/E
5.41
P/B
118.18
P/S
0.89
EV/EBIT
11.54
EV/EBITDA
9.59
EV/Sales
2.18
The company's EPS rose by 40% YoY and by 2.2% QoQ
The price to earnings (P/E) is 5% less than the last 4 quarters average of 5.7
The equity has soared by 169% QoQ and by 107% YoY
The price to sales (P/S) is 27% higher than the last 4 quarters average of 0.7
The revenue has increased by 3.3% year-on-year

Efficiency

How efficient is Organon business performance
The ROA is up by 30% year-on-year
The return on invested capital has declined by 17% year-on-year
The company's return on sales fell by 15% YoY

Dividends

What is OGN's dividend history
DPS
$1.12
Dividend yield
5.05%
Payout ratio
27.3%
Recent dividends

Financial health

How did Organon financials performed over time
OGN's total assets is up by 10% YoY
OGN's current ratio is up by 7% since the previous quarter and by 2.5% year-on-year
The equity has soared by 169% QoQ and by 107% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.